1MAZZAFERRI EL. Management of a solitary thyroid nodule [J] .N Engl J Med, 1993, 328: 553-559.
2ALDRED MA, GINN-PEASE ME, MORRISON CD, et al. Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis [J] . Cancer Res, 2003,63 (11): 2864-2871.
4YING H, SUZUKI H, FURUMOTO H, et al. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma [J] .Carcinogenesis, 2003, 24 (9): 1467-1479.
5CHEN KT, LIN JD, CHAO TC, et al. Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array [J] .Thyroid, 2001, 11 (1): 41-46.
6STOLF BS, ABREU CM, MAHLER-ARAUJO MB, et al. Expression profile of malignant and non-mailgnant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas[J] .Cancer Lett, 2005, 227 (1): 59-73.
7JARIAB B, WIENCH M, FUJAREWICZ K, et al. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications [J] . Cancer Res,2005, 65 (4): 1587-1597.
8BARDEN CB, SHISTER KW, ZHU B, et al. Classification of follicular thyroid tumors by molecular signature:results of gene profiling [J] .Clin Cancer Res, 2003, 9(5): 1792-1800.
9FINLEY DJ, ARORA N, ZHU B, et al. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules [J] . J Clin Endocrinol Metab, 2004,89 (7): 3214-3223.
10XU J, MOATAMED F, CALDWELL JS, et al. Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells [J] . J Clin Endocrinol Metab, 2003, 88 (10): 4990-4996.
